Resonate Blends, Inc. (KOAN)
OTCMKTS · Delayed Price · Currency is USD
0.0110
-0.0009 (-7.56%)
Oct 28, 2025, 3:59 PM EDT
Resonate Blends Revenue
Resonate Blends had revenue of $430.77K in the quarter ending March 31, 2025, with 353.20% growth. This brings the company's revenue in the last twelve months to $2.23M, up 2,100.88% year-over-year. In the year 2024, Resonate Blends had annual revenue of $1.90M with 11,414.54% growth.
Revenue (ttm)
2.23M
Revenue Growth
+2,100.88%
P/S Ratio
1.22
Revenue / Employee
n/a
Employees
6
Market Cap
2.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.90M | 1.88M | 11,414.54% |
| Dec 31, 2023 | 16.47K | -33.03K | -66.73% |
| Dec 31, 2022 | 49.50K | 22.47K | 83.13% |
| Dec 31, 2021 | 27.03K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Resonate Blends News
- 19 days ago - Apollo Biowellness, Inc., Merger Update - Newsfile Corp
- 20 days ago - Apollo Biowellness, Inc., Re-Engages GSS Capital - Newsfile Corp
- 5 weeks ago - Apollo Biowellness, Inc., to Merge with Revive Regenerative, Inc. - Newsfile Corp
- 2 months ago - Apollo Biowellness, Inc., Launches New Product Brand - Newsfile Corp
- 2 months ago - Apollo Biowellness, Inc., Corporate Update - Newsfile Corp
- 3 months ago - Apollo Biowellness, Inc., Outlook for the Remainder of 2025 - Newsfile Corp
- 4 months ago - Apollo Biowellness, Inc. Re-Files Application with OTCMarkets.com - Newsfile Corp
- 4 months ago - Apollo Biowellness, Inc. Announces Exclusive Distribution Deal - Newsfile Corp